WOK

Health Technology
$0.66 -49.23%
Back to Screener
Live Volume
93,682,485
Market Cap
805,210
P/E Ratio
-
52W Peak Proximity
%0

ANALYSIS CENTER

AI Rating & Analysis: WOK stock analysis with hallucination-free AI screener tools — real-time price, volume, P/E ratio, 52-week proximity and sector performance data for Health Technology. AI-powered stock analysis and research platform.
GOD-TIER PROMPT ACTIVE
Investment report at Goldman Sachs + Bridgewater + Renaissance Technologies level
10 sections: Tables • Charts • Bullet Points. Plain text PROHIBITED.
1Executive Summary
2Fair Value
3Fundamental Analysis
4Technical Analysis
5Scenario Analysis
6Competitor Comparison
7Dividend Return
8Risk Analysis
9Catalyst Calendar
10Action Plan
HOW IT WORKS: When you click an AI button below, this prompt is instantly copied to your clipboard. Simply Paste (CTRL+V) it into the chat box of the opened AI assistant to run the analysis.
İpucu: Tip: Use our TradingView charts for technical analysis. Evaluate alongside the AI report.
Open Advanced Chart
TradingView Charts
• 15-min delayed price feed • 100+ technical indicators • Sub-second updates • Professional drawing tools
Affiliate links — DocuRefinery may earn a commission when you open an account.

Interactive Brokers

SEC, FINRA, FCA, ASIC Regulation $0 Min. Deposit
Access 150+ global markets. Stocks, ETFs, Options, Futures, Forex.
Open Account

TD Ameritrade (Schwab)

SEC, FINRA Regulation $0 Min. Deposit
Industry-leading trading platforms and comprehensive education.
Open Account
All investing involves risk, including the possible loss of principal. Past performance does not guarantee future results.

Latest News — WOK

WORK Medical Technology Group LTD — Company Profile & Analysis

Founded in 2002 and headquartered in Hangzhou, China, WORK Medical Technology Group LTD has evolved into a prominent manufacturer and supplier of medical consumables and specialized medical devices. Since its inception, the company has been driven by a core mission to enhance global healthcare standards through the delivery of high-quality, reliable, and cost-effective medical solutions. Over the past two decades, the firm has built a robust operational foundation, transitioning from a local manufacturer to a significant player in the international medical technology landscape. By maintaining a steadfast commitment to quality control and continuous improvement, the company has successfully established itself as a trusted partner for healthcare providers worldwide.

The company’s product portfolio is extensive, covering critical areas such as anesthesia, respiratory care, and personal protective equipment. Key offerings include endotracheal tubes, laryngeal mask airways, anesthesia kits, oxygen face masks, and heat and moisture exchanging filters, alongside specialized devices like visualized prostatic dilatation catheters and artery compression tourniquets. Beyond traditional medical consumables, the company has demonstrated agility by producing KN95 masks and various hygiene products. A significant technological milestone is the company's strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd., which focuses on developing a 'data-model-application' trinity for intelligent medical models, signaling a shift toward data-driven healthcare solutions.

With a global footprint spanning approximately 30 countries across Asia, Africa, Europe, North America, South America, and Oceania, WORK Medical Technology Group serves a diverse clientele, including hospitals, pharmacies, and various medical institutions. This extensive reach is supported by a sophisticated supply chain and a deep understanding of international regulatory requirements, allowing the company to maintain a competitive edge in diverse markets. By catering to the specific needs of healthcare professionals across different continents, the company has solidified its reputation as a reliable link in the global medical supply chain.

Looking ahead, the company’s strategic direction is centered on the convergence of traditional medical manufacturing and advanced digital health technologies. By investing heavily in research and development, particularly in the fields of biological and medical technology, the company aims to transition from a hardware-focused manufacturer to a comprehensive medical solutions provider. The integration of artificial intelligence and data analytics into their product offerings is expected to drive future growth and differentiation. As the global healthcare sector continues to prioritize efficiency and patient outcomes, WORK Medical Technology Group is well-positioned to leverage its technical expertise and market presence to capture emerging opportunities in the intelligent medical device market.

Economic Moat The company's sustainable competitive advantage lies in its vertically integrated manufacturing capabilities combined with a well-established, multi-continental distribution network. Furthermore, its strategic pivot toward AI-integrated medical models through high-level research partnerships creates a significant barrier to entry for traditional competitors.
CEO Mr. Shuang Wu
Employees 238
Headquarters China
Market Competitors
Smart Tags
#MedTech #HealthcareInnovation #MedicalDevices #GlobalHealth #Biotech #HangzhouTech

Market Insights & Investor Q&A — WOK

Frequently Asked Questions

What company does the WOK ticker symbol represent?
The WOK ticker symbol represents a stock listed on U.S. exchanges. If the company's real name is unknown, use only the 'WOK' ticker. Company information can be accessed through DocuRefinery's AI-powered analysis tools.
What sector does the WOK stock belong to?
The WOK stock typically belongs to the technology or financial services sector. However, sector information can be dynamically determined using AI prompts. DocuRefinery's pre-built prompts accelerate such analyses.
What tools are available for analyzing the WOK stock?
DocuRefinery platform offers AI-powered prompts for analyzing stocks like WOK. These prompts include functions such as risk analysis, trend detection, and balance sheet scanning. Users can create professional analyses with these prompts.

Deep Analysis

AI-Supported Ready Solutions for WOK Investment Analysis

Investors can use AI-powered pre-built prompts to analyze stocks like WOK instead of traditional methods. These prompts automate critical functions like risk analysis and trend detection, saving time and resources. DocuRefinery's platform enables these analyses to be completed in just a few minutes.

AI-driven analysis delivers faster and more efficient results compared to traditional methods. Complex tasks such as multi-dimensional peer analysis can be easily performed using DocuRefinery's templates, giving investors access to more comprehensive data sets.

Prompt engineering offers a significant advantage in customizing analysis strategies. Users can tailor DocuRefinery's templates to their specific needs, enabling more personalized results and better decision-making processes in stock analysis.